# Recro Pharma Inc. (REPH)

Source: https://www.quantisnow.com/company/REPH
Generated: 2026-11-16T11:54:59.518Z

- Ticker: REPH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- Website: recrogainesville.com

## About

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.

## Latest REPH news and filings

- 2024-02-14 20:53 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-recro-pharma-inc-amendment-5262660)
- 2024-02-14 19:27 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-recro-pharma-inc-amendment-5262063)
- 2024-02-06 22:31 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 1,022 shares, decreasing direct ownership by 0.13% to 800,557 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-1022-shares-decreasing-5234811)
- 2024-01-26 23:00 UTC [SEC Form 4] [Enloe J David Jr was granted 196,474 shares, increasing direct ownership by 18% to 1,295,414 units (SEC Form 4)](https://www.quantisnow.com/insight/enloe-j-david-jr-was-granted-196474-shares-increasing-direct-5211929)
- 2024-01-26 22:59 UTC [SEC Form 4] [Lake Ryan David was granted 110,025 shares and covered exercise/tax liability with 37,453 shares, increasing direct ownership by 10% to 801,579 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-was-granted-110025-shares-and-covered-exercisetax-5211927)
- 2024-01-23 22:39 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 34,096 shares, decreasing direct ownership by 4% to 729,007 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-34096-shares-decreasing-5202462)
- 2024-01-04 22:02 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 1,419 shares, decreasing direct ownership by 0.19% to 763,103 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-1419-shares-decreasing-5170629)
- 2023-12-19 21:23 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 5,690 shares, decreasing direct ownership by 0.74% to 764,522 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-5690-shares-decreasing-5146573)
- 2023-12-04 21:03 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 0.16% to 770,212 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-1197-shares-decreasing-5116463)
- 2023-11-28 21:14 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-entry-into-a-5106736)
- 2023-11-08 21:13 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-recro-pharma-inc-5070469)
- 2023-11-08 21:11 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-results-of-operations-5070437)
- 2023-11-02 20:47 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.16% to 771,409 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-1198-shares-decreasing-5056127)
- 2023-10-04 20:19 UTC [SEC Form 4] [Lake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.15% to 772,607 units (SEC Form 4)](https://www.quantisnow.com/insight/lake-ryan-david-covered-exercisetax-liability-with-1198-shares-decreasing-5004662)
- 2023-09-20 20:10 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-costs-associated-with-4980708)
- 2023-09-05 20:30 UTC [SEC Form 4] [SEC Form 4: Lake Ryan David covered exercise/tax liability with 1,197 shares, decreasing direct ownership by 0.15% to 773,805 units](https://www.quantisnow.com/insight/sec-form-4-lake-ryan-david-covered-exercisetax-liability-with-4953453)
- 2023-08-31 15:59 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-recro-pharma-inc-4947531)
- 2023-08-28 20:33 UTC [SEC Form 4] [SEC Form 4: Ashton William bought $10,111 worth of shares (22,222 units at $0.46), increasing direct ownership by 9% to 263,622 units](https://www.quantisnow.com/insight/sec-form-4-ashton-william-bought-10111-worth-of-shares-4941179)
- 2023-08-28 20:32 UTC [SEC Form 4] [SEC Form 4: Reasons Bryan M. bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 27% to 291,049 units](https://www.quantisnow.com/insight/sec-form-4-reasons-bryan-m-bought-25000-worth-of-4941170)
- 2023-08-28 20:31 UTC [SEC Form 4] [SEC Form 4: Weisman Wayne bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 25% to 308,602 units](https://www.quantisnow.com/insight/sec-form-4-weisman-wayne-bought-25000-worth-of-shares-4941161)
- 2023-08-28 20:31 UTC [SEC Form 4] [SEC Form 4: Miller James Charles bought $15,000 worth of shares (37,500 units at $0.40), increasing direct ownership by 20% to 227,543 units](https://www.quantisnow.com/insight/sec-form-4-miller-james-charles-bought-15000-worth-of-4941156)
- 2023-08-28 20:30 UTC [SEC Form 4] [SEC Form 4: Cant Elena bought $12,000 worth of shares (30,000 units at $0.40), increasing direct ownership by 41% to 103,620 units](https://www.quantisnow.com/insight/sec-form-4-cant-elena-bought-12000-worth-of-shares-4941150)
- 2023-08-28 20:30 UTC [SEC Form 4] [SEC Form 4: Churchill Winston J bought $25,000 worth of shares (62,500 units at $0.40), increasing direct ownership by 26% to 301,602 units](https://www.quantisnow.com/insight/sec-form-4-churchill-winston-j-bought-25000-worth-of-4941145)
- 2023-08-28 20:21 UTC [SEC Form 4] [SEC Form 4: Awm Investment Company, Inc. bought $56,000 worth of shares (140,000 units at $0.40)](https://www.quantisnow.com/insight/sec-form-4-awm-investment-company-inc-bought-56000-worth-4941072)
- 2023-08-26 00:06 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-recro-pharma-inc-4939725)
- 2023-08-26 00:08 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-entry-into-a-4939718)
- 2023-08-25 20:25 UTC [SEC Form 4] [SEC Form 4: Arens Mathew Paul bought $2,500,000 worth of shares (6,250,000 units at $0.40)](https://www.quantisnow.com/insight/sec-form-4-arens-mathew-paul-bought-2500000-worth-of-4939081)
- 2023-08-25 20:22 UTC [SEC Form 3] [SEC Form 3: New insider Arens Mathew Paul claimed ownership of 14,061,396 shares](https://www.quantisnow.com/insight/sec-form-3-new-insider-arens-mathew-paul-claimed-ownership-4939065)
- 2023-08-25 20:18 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-recro-pharma-inc-4939046)
- 2023-08-23 20:38 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-recro-pharma-inc-4934993)
- 2023-08-23 20:13 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-leadership-update-4934748)
- 2023-08-14 21:10 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-recro-pharma-inc-4896132)
- 2023-08-14 20:28 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-results-of-operations-4894950)
- 2023-08-07 19:27 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-recro-pharma-inc-4855596)
- 2023-08-02 21:13 UTC [SEC Form 4] [SEC Form 4: Lake Ryan David covered exercise/tax liability with 1,198 shares, decreasing direct ownership by 0.15% to 775,002 units](https://www.quantisnow.com/insight/sec-form-4-lake-ryan-david-covered-exercisetax-liability-with-4836894)
- 2023-07-05 20:19 UTC [SEC Form 4] [SEC Form 4 filed by Lake Ryan David](https://www.quantisnow.com/insight/sec-form-4-filed-by-lake-ryan-david-4721178)
- 2023-06-06 20:37 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Recro Pharma Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-recro-pharma-inc-amendment-4610214)
- 2023-06-02 20:31 UTC [SEC Form 4] [SEC Form 4 filed by Lake Ryan David](https://www.quantisnow.com/insight/sec-form-4-filed-by-lake-ryan-david-4597449)
- 2023-05-26 20:04 UTC [SEC Form 8-K] [Recro Pharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/recro-pharma-inc-filed-sec-form-8-k-notice-of-delisting-4568046)
- 2023-05-22 21:10 UTC [SEC Form 144] [SEC Form 144 filed by Recro Pharma Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-recro-pharma-inc-4541249)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/REPH
- Earnings history: https://www.quantisnow.com/earnings/REPH
- Dividend history: https://www.quantisnow.com/dividends/REPH
- Insider transactions: https://www.quantisnow.com/insiders/REPH
- Options chain: https://www.quantisnow.com/options/REPH
- SEC 8-K filings only: https://www.quantisnow.com/company/REPH/8-k
- RSS and alerts for REPH: https://www.quantisnow.com/docs/rss-feeds.md
